Gilbert Lynn Marks - Dec 19, 2024 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Director
Signature
/s/ Joshua Eizen, Attorney-in-Fact for Gilbert Lynn Marks
Stock symbol
ANTX
Transactions as of
Dec 19, 2024
Transactions value $
$0
Form type
4
Date filed
12/23/2024, 06:38 PM
Previous filing
Jun 21, 2024
Next filing
Apr 11, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Award $0 +8.97K +39.3% $0.00 31.8K Dec 19, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued in lieu of cash compensation under the issuer's non-employee director compensation policy. All shares vest immediately.